Institute Scholars

Steven Banik receives Hypothesis Fund Award for his transformative work in endosomal membrane manipulation to improve drug delivery.

Two selected projects involve ChEM-H Institute Scholars Carolyn Bertozzi, Christopher Barnes, Peter Kim, Christine Jacobs-Wagner, Laura Dassama, and Steven Banik.

Carolyn Bertozzi's 2022 Nobel Prize Lecture

SVT Nobel Prize Portrait

National Academy of Medicine Elects 100 New Members including Institute Scholar Paul Mischel

Baker Family Director of Sarafan ChEM-H wins the 2022 Nobel Prize in chemistry

Six Stanford researchers including Institute Scholar Michael Fischbach receive the NIH High-Risk, High-Reward grants

Institute Scholar Christopher Barnes is on a quest for a universal coronavirus vaccine

New study led by Institute Scholar Monther Abu-Remaileh allows scientists to determine all the molecules present in the lysosomes of any cell in mice.

Institute Scholar Michael Fischbach led a team of researchers at Stanford that built a complex, well-defined synthetic microbiome for the broader research community.

Institute Scholar Polly Fordyce, Chris Garcia & team developed a new platform to predict, faster & more accurately, which antigens trigger a strong and specific T cell response.

Dr. Bertozzi was recognized for being a leading figure in the field of chemical biology and making major discoveries about the nature of cell surface chemistry.

Cryogenic electron microscopy is driving a burst of discoveries about how molecules work in health and disease

Cancer’s deadly weapon – rings of DNA – have been hiding in plain sight

The Barnes lab excels in leveraging interdisciplinary approaches to address fundamental principles of viral-host interactions for therapeutic benefit.

Our Director Carolyn Bertozzi, who founded the field of bioorthogonal chemistry, has been awarded 2022 Dickson Prize in Medicine.

The team will receive $25m to develop next-generation immunotherapies for children with solid tumors.

The team will receive $25m to better understand ecDNA and provide a path to develop new therapies for difficult-to-treat cancers.

Institute Scholar Jonathan Long and collaborators have identified a molecule that staves off hunger post-exercise.